August 23, 2013

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

.   .   

This longer term follow-up of PLEX for the treatment of ANCA-associated vasculitis in patients with severely impaired renal function are disappointing. The data suggest that PLEX does not significantly benefit these patients. Current trials are ongoing as to the role of PLEX in ANCA-associated vasculitis.

Related Articles:

Clinical Trial Results, Glomerulonephritis

Comments are closed.